APA (7th ed.) Citation

Vallejo, C., Meaney, C., Clemens, L., Yang, K., Lukacova, V., & Zhou, H. Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. MDPI AG.

Chicago Style (17th ed.) Citation

Vallejo, Celeste, Cameron Meaney, Lara Clemens, Kyunghee Yang, Viera Lukacova, and Haiying Zhou. Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. MDPI AG.

MLA (9th ed.) Citation

Vallejo, Celeste, et al. Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations. MDPI AG.